Why the study?
The study aimed to investigate changes in AgNOR proteins, which increase in hypoxia, in patients with non-ST elevation myocardial infarction.
Are AgNOR proteins elevated in patients with NSTEMI compared to controls without acute coronary syndrome?
Are AgNOR proteins elevated in patients with NSTEMI compared to controls without acute coronary syndrome?
AgNOR proteins are significantly elevated in patients with NSTEMI compared to controls, suggesting they may serve as a marker of hypoxic response in acute coronary syndromes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Damar et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: